NSC139021

CAS No. 1147-56-4

NSC139021 ( ERGi-USU )

Catalog No. M20631 CAS No. 1147-56-4

NSC139021 is a Rio2 kinase (RIOK2) inhibitor that inhibits ERG protein.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC139021
  • Note
    Research use only not for human use.
  • Brief Description
    NSC139021 is a Rio2 kinase (RIOK2) inhibitor that inhibits ERG protein.
  • Description
    NSC139021 is a Rio2 kinase (RIOK2) inhibitor that inhibits ERG protein.
  • Synonyms
    ERGi-USU
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Rio2 kinase (RIOK2)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1147-56-4
  • Formula Weight
    255.3
  • Molecular Formula
    C13H9N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62 mg/mL (242.85 mM)
  • SMILES
    Oc1ccc2ccccc2c1N=Nc1nccs1
  • Chemical Name
    1-[2-(2-Thiazolyl)diazenyl]-2-naphthalenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mohamed A A Xavier C P Sukumar G et al. Identification of a small molecule that selectively inhibits ERG-positive cancer cell growth[J]. Cancer Research 2018:canres.2949.2017.
molnova catalog
related products
  • Mini Gastrin I, huma...

    Mini Gastrin I, human (TFA) is short for human Gastrin. It is a mother peptide composed of 5-17 amino acids.

  • PACAP (6-38), human,...

    PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.

  • tetrahydroxyl diphen...

    EH-201 is a low MW inducer of erythropoietin. EH-201 induces expression of erythropoietin PPAR-γ coactivator 1α (PGC-1α) and haemoglobin in astrocytes and PC12 neuronal-like cells. In vivo EH-201 treatment restores memory impairment as assessed by the passive avoidance test in SD Aβ and KA mouse models.